Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prospective Risk Factor Evaluation and Discovery In Chronic Thromboembolic Pulmonary Hypertension Study

NCT03470207 is registered in ClinicalTrials.gov with Mark W. Dodson as lead sponsor.

NCT NCT03470207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03470207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prospective Risk Factor Evaluation and Discovery In Chronic Thromboembolic Pulmonary Hypertension Study
Lead sponsor
Mark W. Dodson
Phase
Not applicable
Overall status
Unknown status
Start date
April 17, 2018
Completion date
August 31, 2021
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension